222 related articles for article (PubMed ID: 36913408)
1. Clinical isolates of Candida auris with enhanced adherence and biofilm formation due to genomic amplification of ALS4.
Bing J; Guan Z; Zheng T; Zhang Z; Fan S; Ennis CL; Nobile CJ; Huang G
PLoS Pathog; 2023 Mar; 19(3):e1011239. PubMed ID: 36913408
[TBL] [Abstract][Full Text] [Related]
2. Biofilm formation by Candida auris isolated from colonising sites and candidemia cases.
Singh R; Kaur M; Chakrabarti A; Shankarnarayan SA; Rudramurthy SM
Mycoses; 2019 Aug; 62(8):706-709. PubMed ID: 31132181
[TBL] [Abstract][Full Text] [Related]
3. Candida auris Phenotypic Heterogeneity Determines Pathogenicity
Brown JL; Delaney C; Short B; Butcher MC; McKloud E; Williams C; Kean R; Ramage G
mSphere; 2020 Jun; 5(3):. PubMed ID: 32581078
[No Abstract] [Full Text] [Related]
4. The Emerging Pathogen Candida auris: Growth Phenotype, Virulence Factors, Activity of Antifungals, and Effect of SCY-078, a Novel Glucan Synthesis Inhibitor, on Growth Morphology and Biofilm Formation.
Larkin E; Hager C; Chandra J; Mukherjee PK; Retuerto M; Salem I; Long L; Isham N; Kovanda L; Borroto-Esoda K; Wring S; Angulo D; Ghannoum M
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223375
[No Abstract] [Full Text] [Related]
5. Virulence of
Hernando-Ortiz A; Mateo E; Perez-Rodriguez A; de Groot PWJ; Quindós G; Eraso E
Virulence; 2021 Dec; 12(1):1063-1075. PubMed ID: 33843456
[No Abstract] [Full Text] [Related]
6. Characterization of the Differential Pathogenicity of Candida auris in a Galleria mellonella Infection Model.
Garcia-Bustos V; Ruiz-Saurí A; Ruiz-Gaitán A; Sigona-Giangreco IA; Cabañero-Navalon MD; Sabalza-Baztán O; Salavert-Lletí M; Tormo MÁ; Pemán J
Microbiol Spectr; 2021 Sep; 9(1):e0001321. PubMed ID: 34106570
[TBL] [Abstract][Full Text] [Related]
7. The Two-Component Response Regulator Ssk1 and the Mitogen-Activated Protein Kinase Hog1 Control Antifungal Drug Resistance and Cell Wall Architecture of Candida auris.
Shivarathri R; Jenull S; Stoiber A; Chauhan M; Mazumdar R; Singh A; Nogueira F; Kuchler K; Chowdhary A; Chauhan N
mSphere; 2020 Oct; 5(5):. PubMed ID: 33055262
[No Abstract] [Full Text] [Related]
8. Biofilm-Forming Capability of Highly Virulent, Multidrug-Resistant Candida auris.
Sherry L; Ramage G; Kean R; Borman A; Johnson EM; Richardson MD; Rautemaa-Richardson R
Emerg Infect Dis; 2017 Feb; 23(2):328-331. PubMed ID: 28098553
[TBL] [Abstract][Full Text] [Related]
9. Genomic Diversity across Candida auris Clinical Isolates Shapes Rapid Development of Antifungal Resistance
Burrack LS; Todd RT; Soisangwan N; Wiederhold NP; Selmecki A
mBio; 2022 Aug; 13(4):e0084222. PubMed ID: 35862787
[TBL] [Abstract][Full Text] [Related]
10. A Novel Robust Method Mimicking Human Substratum To Dissect the Heterogeneity of Candida auris Biofilm Formation.
Biswas B; Rana A; Gupta N; Gupta I; Puria R; Thakur A
Microbiol Spectr; 2023 Aug; 11(4):e0089223. PubMed ID: 37439683
[TBL] [Abstract][Full Text] [Related]
11. Transcriptome Assembly and Profiling of
Kean R; Delaney C; Sherry L; Borman A; Johnson EM; Richardson MD; Rautemaa-Richardson R; Williams C; Ramage G
mSphere; 2018 Jul; 3(4):. PubMed ID: 29997121
[No Abstract] [Full Text] [Related]
12. Four genomic clades of Candida auris identified in Canada, 2012-2019.
De Luca DG; Alexander DC; Dingle TC; Dufresne PJ; Hoang LM; Kus JV; Schwartz IS; Mulvey MR; Bharat A
Med Mycol; 2022 Jan; 60(1):. PubMed ID: 34910140
[TBL] [Abstract][Full Text] [Related]
13. Rapid evolution of an adaptive multicellular morphology of Candida auris during systemic infection.
Bing J; Guan Z; Zheng T; Ennis CL; Nobile CJ; Chen C; Chu H; Huang G
Nat Commun; 2024 Mar; 15(1):2381. PubMed ID: 38493178
[TBL] [Abstract][Full Text] [Related]
14. Liposomal formulation of a new antifungal hybrid compound provides protection against
Jaromin A; Zarnowski R; Markowski A; Zagórska A; Johnson CJ; Etezadi H; Kihara S; Mota-Santiago P; Nett JE; Boyd BJ; Andes DR
Antimicrob Agents Chemother; 2024 Jan; 68(1):e0095523. PubMed ID: 38092678
[TBL] [Abstract][Full Text] [Related]
15. Activity of anti-CR3-RP polyclonal antibody against biofilms formed by Candida auris, a multidrug-resistant emerging fungal pathogen.
Dekkerová J; Lopez-Ribot JL; Bujdáková H
Eur J Clin Microbiol Infect Dis; 2019 Jan; 38(1):101-108. PubMed ID: 30327897
[TBL] [Abstract][Full Text] [Related]
16. Intra-clade Heterogeneity in Candida auris: Risk of Management.
Fayed B; Lazreg IK; AlHumaidi RB; Qasem MAAA; Alajmy BMGN; Bojbarah FMAM; Senok A; Husseiny MI; Soliman SSM
Curr Microbiol; 2023 Jul; 80(9):295. PubMed ID: 37486431
[TBL] [Abstract][Full Text] [Related]
17.
Romera D; Aguilera-Correa JJ; Gadea I; Viñuela-Sandoval L; García-Rodríguez J; Esteban J
J Med Microbiol; 2019 Sep; 68(9):1353-1358. PubMed ID: 31271350
[No Abstract] [Full Text] [Related]
18. Transcriptional Profiling of the Candida auris Response to Exogenous Farnesol Exposure.
Jakab Á; Balla N; Ragyák Á; Nagy F; Kovács F; Sajtos Z; Tóth Z; Borman AM; Pócsi I; Baranyai E; Majoros L; Kovács R
mSphere; 2021 Oct; 6(5):e0071021. PubMed ID: 34643421
[TBL] [Abstract][Full Text] [Related]
19. Abrogation of pathogenic attributes in drug resistant Candida auris strains by farnesol.
Srivastava V; Ahmad A
PLoS One; 2020; 15(5):e0233102. PubMed ID: 32392266
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of
Lara HH; Ixtepan-Turrent L; Jose Yacaman M; Lopez-Ribot J
ACS Appl Mater Interfaces; 2020 May; 12(19):21183-21191. PubMed ID: 31944650
[No Abstract] [Full Text] [Related]
[Next] [New Search]
